Gagnon Advisors Has Cut Its Caredx (CDNA) Position as Stock Value Declined; Intel (INTC) Holder Bridgecreek Investment Management Has Raised Its Stake by $373,350 as Market Value Declined

February 21, 2018 - By Marguerite Chambers

Bridgecreek Investment Management Llc increased its stake in Intel Corp (INTC) by 9.05% based on its latest 2017Q3 regulatory filing with the SEC. Bridgecreek Investment Management Llc bought 9,825 shares as the company’s stock declined 2.96% while stock markets rallied. The institutional investor held 118,400 shares of the semiconductors company at the end of 2017Q3, valued at $4.51 million, up from 108,575 at the end of the previous reported quarter. Bridgecreek Investment Management Llc who had been investing in Intel Corp for a number of months, seems to be bullish on the $216.78 billion market cap company. The stock increased 1.67% or $0.76 during the last trading session, reaching $46.32. About 25.51M shares traded. Intel Corporation (NASDAQ:INTC) has risen 19.47% since February 21, 2017 and is uptrending. It has outperformed by 2.77% the S&P500.

Gagnon Advisors Llc decreased its stake in Caredx Inc (CDNA) by 99.63% based on its latest 2017Q3 regulatory filing with the SEC. Gagnon Advisors Llc sold 950,736 shares as the company’s stock declined 53.04% while stock markets rallied. The hedge fund held 3,536 shares of the health care company at the end of 2017Q3, valued at $3.54 million, down from 954,272 at the end of the previous reported quarter. Gagnon Advisors Llc who had been investing in Caredx Inc for a number of months, seems to be less bullish one the $159.32M market cap company. The stock decreased 2.45% or $0.14 during the last trading session, reaching $5.57. About 74,570 shares traded. CareDx, Inc (NASDAQ:CDNA) has declined 74.10% since February 21, 2017 and is downtrending. It has underperformed by 90.80% the S&P500.

Since October 2, 2017, it had 0 insider purchases, and 16 insider sales for $30.87 million activity. Krzanich Brian M sold $427,757 worth of stock or 8,659 shares. The insider BRYANT ANDY D sold $3.99 million. $20.89M worth of Intel Corporation (NASDAQ:INTC) shares were sold by Smith Stacy J. 1,502 shares were sold by RENDUCHINTALA VENKATA S M, worth $66,959 on Wednesday, February 7. On Monday, October 30 YOFFIE DAVID B sold $1.35 million worth of Intel Corporation (NASDAQ:INTC) or 30,000 shares. 1,639 shares were sold by Bryant Diane M, worth $67,048.

Among 54 analysts covering Intel Corporation (NASDAQ:INTC), 36 have Buy rating, 5 Sell and 13 Hold. Therefore 67% are positive. Intel Corporation has $60.0 highest and $25 lowest target. $45.10’s average target is -2.63% below currents $46.32 stock price. Intel Corporation had 222 analyst reports since August 7, 2015 according to SRatingsIntel. Summit Research upgraded the stock to “Buy” rating in Wednesday, October 14 report. The stock of Intel Corporation (NASDAQ:INTC) has “Buy” rating given on Friday, July 28 by Needham. TH Capital maintained Intel Corporation (NASDAQ:INTC) rating on Friday, January 15. TH Capital has “Buy” rating and $36.0 target. The rating was maintained by Deutsche Bank with “Buy” on Thursday, July 21. Robert W. Baird maintained Intel Corporation (NASDAQ:INTC) rating on Monday, September 4. Robert W. Baird has “Buy” rating and $45.0 target. The stock has “Hold” rating by BMO Capital Markets on Monday, October 16. The stock has “Mkt Perform” rating by JMP Securities on Friday, September 25. The stock of Intel Corporation (NASDAQ:INTC) has “Neutral” rating given on Wednesday, June 21 by Bank of America. As per Wednesday, July 12, the company rating was maintained by Needham. Drexel Hamilton downgraded it to “Hold” rating and $30 target in Friday, August 7 report.

Investors sentiment is 1.03 in Q3 2017. Its the same as in 2017Q2. It is without change, as 52 investors sold INTC shares while 663 reduced holdings. only 127 funds opened positions while 608 raised stakes. 3.05 billion shares or 0.19% more from 3.05 billion shares in 2017Q2 were reported. Umb Bankshares N A Mo owns 0.32% invested in Intel Corporation (NASDAQ:INTC) for 246,678 shares. Bancorporation holds 1.18M shares. Boston Family Office Ltd Liability reported 0.42% stake. Ar Asset Management Inc invested in 55,500 shares or 0.84% of the stock. Foundry Partners Ltd Liability Com, a Minnesota-based fund reported 14,702 shares. Harris Assoc Lp holds 0.98% of its portfolio in Intel Corporation (NASDAQ:INTC) for 15.28 million shares. Old Mutual Customised Solutions (Proprietary) Limited holds 1% or 192,703 shares in its portfolio. Cullen Capital Management Lc stated it has 2.21% of its portfolio in Intel Corporation (NASDAQ:INTC). Mckinley Carter Wealth Svcs Incorporated holds 0.17% or 11,775 shares. Ally Finance reported 1.34% stake. Trustmark Comml Bank Trust Department has invested 0.47% of its portfolio in Intel Corporation (NASDAQ:INTC). 89,820 are held by Boyer And Corporon Wealth Mngmt Ltd Limited Liability Company. 20,371 are owned by Telemus Limited Co. Regent Mgmt Limited Co owns 34,163 shares or 0.44% of their US portfolio. Oarsman has 1.09% invested in Intel Corporation (NASDAQ:INTC).

Bridgecreek Investment Management Llc, which manages about $625.00M and $368.14 million US Long portfolio, decreased its stake in Wynn Resorts Ltd (NASDAQ:WYNN) by 2,275 shares to 76,440 shares, valued at $11.38 million in 2017Q3, according to the filing. It also reduced its holding in Under Armour Inc Cl A (NYSE:UA) by 232,990 shares in the quarter, leaving it with 17,500 shares, and cut its stake in At&T Inc (NYSE:T).

Among 5 analysts covering CareDx (NASDAQ:CDNA), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. CareDx has $13 highest and $3.0 lowest target. $10’s average target is 79.53% above currents $5.57 stock price. CareDx had 10 analyst reports since September 25, 2015 according to SRatingsIntel. The company was maintained on Wednesday, January 31 by H.C. Wainwright. The firm has “Buy” rating given on Friday, September 25 by Craig Hallum. The firm earned “Buy” rating on Tuesday, June 14 by Mizuho. The rating was maintained by Piper Jaffray with “Buy” on Sunday, September 24. As per Wednesday, September 27, the company rating was upgraded by Raymond James. The stock of CareDx, Inc (NASDAQ:CDNA) earned “Buy” rating by Piper Jaffray on Monday, January 8. The firm earned “Buy” rating on Monday, October 9 by Craig Hallum. On Monday, September 28 the stock rating was downgraded by Raymond James to “Market Perform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: